Zurich, Switzerland
Established in November 1993, BB Biotech AG is an investment firm that concentrates on global biotech companies. Over time, BB Biotech has emerged as one of the biggest investors that prioritizes biotech investments exclusively. The company's shares are traded on the Swiss Stock Market and are included in the "TecDax" in Germany and the Italian "Star-Segment." BB Biotech presents its investors with the chance to partake in biotech growth and benefit from potential exceptional appreciation.
31
Total Investments
19
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BB Biotech Ventures
Recent Investments (31)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Post-IPO Equity | •••••• | Mar 2024 | |
| Post-IPO Equity | •••••• | Jul 2023 | |
| Series B | •••••• | Sep 2022 | |
| Venture Round | •••••• | Mar 2020 | |
| Series E | •••••• | Dec 2019 | |
•••• ••••
|
Series G | •••••• | Feb 2018 |
|
•••• ••••
|
Series D | •••••• | Jan 2017 |
|
•••• ••••
|
Venture Round | •••••• | Dec 2016 |
|
•••• ••••
|
Series C | •••••• | May 2016 |
|
•••• ••••
|
Series C | •••••• | Jan 2015 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
